Scott R. Ward - Feb 7, 2022 Form 4 Insider Report for Cardiovascular Systems Inc (CSII)

Signature
/s/ Andrew Nick as Attorney-in-Fact for Scott R. Ward pursuant to Power of Attorney previously filed.
Stock symbol
CSII
Transactions as of
Feb 7, 2022
Transactions value $
$46,293
Form type
4
Date filed
2/9/2022, 03:15 PM
Previous filing
Aug 31, 2021
Next filing
May 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CSII Common Stock Purchase $46.3K +2.5K +0.44% $18.52 572K Feb 7, 2022 Direct F1
transaction CSII Common Stock Award $0 +5.48K +0.96% $0.00 578K Feb 8, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CSII Restricted Stock Units 34.3K Feb 7, 2022 Common Stock 34.3K Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.50 to $18.58 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 Restrictions lapse as to 2,739 shares on 2/12/23 and as to 2,738 shares on 2/12/24.
F3 Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of the Company's common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership.